AXM Pharma, Inc.

OTC: AXMP · Healthcare · Medical - Pharmaceuticals

PublicHQ Las Vegas, Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 20

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ market scale, listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-08-08

Market cap

$409

as of 2026-08-08

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is AXM Pharma, Inc.’s financial profile?

AXM Pharma, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

HLK Biotech Holding Group, Inc.——Sunset Island Group, Inc.——NxGen Brands Inc.——Hear AtLast Holdings, Inc.——Ormand Industries Inc——Coenzyme-A Inc.——

Key facts

CEOLinda L. Forster

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersLas Vegas, null

ExchangeOTC: AXMP

Employees—

IPO date2018-10-15

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.